Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

Aurora Cannabis Inc. closed 29.30% below its 52-week high of $9.35, which the company reached on April 30th.

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

Consumer Cannabis Revenue: $9.9 million, down from $11.6 million last year. Aurora Cannabis Inc (NASDAQ:ACB) reported a record third quarter for medical cannabis revenue, net income, adjusted ...

Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The company has a market capitalization of $330.81 million, a PE ratio of -7.93 and a beta of 1.85.

Get Our Latest Research Report on Aurora Cannabis Aurora Cannabis Trading Down 3.7 % TSE:ACB opened at C$8.63 on Friday. The stock’s 50 day moving average price is C$6.08 and its 200 day moving ...

Aurora Cannabis (ACB) announces a strategic supply agreement with SNDL Inc, (SNDL) a Canadian licensed producer and vertically integrated ...